Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CEP55 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOXL1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ELOVL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2N - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CHN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM120A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHAC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RACGAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NBPF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPHN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RECQL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD13C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CERS6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTGR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on